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Next generation microfluidic platforms for high-throughput
protein biochemistry
Sebastian J MaerklDNA technologies such as cloning, DNA microarrays, and next
generation sequencing have transformed the life sciences.
Protein technologies on the other hand have not seen such
explosive progress. This is mainly due to the inherent difficulty
of working with proteins because of their manifold physical
characteristics as opposed to the well behaved and well
understood DNA polymer. Recent technological
advancements have increased the throughput of protein
biochemistry to levels where it is becoming of interest to
systems biology. Here I review methods for high-throughput in
situ synthesis and characterization of proteins and their
integration with microfluidic devices. In the near future, the use
of gene synthesis, microfluidic based protein synthesis and
characterization will give rise to a resurgence of protein
biochemistry in the current world of high-throughput genomics.
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Introduction
Proteins are the arbiters of cellular function; they control
cell division, transduce internal and external signals, and
regulate the expression state of the genome, in addition
to performing a plethora of other functions. All these
functions require proteins to bind to other proteins,
DNA, RNA, or small molecules. The resulting com-
plexes can either be directly functional, or lead to func-
tional modifications such as phosphorylation of the
components of the complex. It is these interactions
and enzymatic activities that allow proteins to perform
such diverse functions. Proteins are uniquely suited to
these tasks as they are built from 20 different building
blocks, that can be combined in an astronomically large
number of ways, giving rise to proteins with many differ-
ent folds and physical characteristics. It is this enormous
plasticity that makes proteins such fantastic all-purposePlease cite this article in press as: Maerkl SJ. Next generation microfluidic platforms for high-thro
www.sciencedirect.commachines, but is also the very reason why working with
proteins is difficult.
Many useful methods have been developed for working
with and manipulating DNA (incidentally almost all of
them are based on proteins). DNA can be cut at precise
positions using restriction enzymes, combined together
with ligases, and amplified with polymerases. DNA can
also be chemically synthesized, purified, and sequenced.
For proteins these methods are either much more labour
intensive (purification, synthesis, and sequencing) or do
not exist at all (digestion, ligation, amplification). This
lack of simple and scalable methods for protein biochem-
istry severely impacts the amount of time and effort
researchers need to invest in characterizing a protein,
leaving protein biochemistry in the low-throughput, pre-
genomic era.
The difference between protein and DNA is well exem-
plified by comparing DNA and protein microarrays and
the respective impact each has had on the life sciences.
The first DNA arrays were generated by physically spot-
ting cDNAs generated with PCR and synthesized oligos
[1]. These oligos were obtained by synthesis in high-
throughput and yield, and the PCR could produce large
quantities of DNA for spotting. The PCR product could
also be purified in sufficient amounts to generate hun-
dreds of DNA microarrays. Other advances to generating
DNA microarrays included the photolithographic syn-
thesis of oligos directly on the glass substrate at high
spot densities [2,3]. For the detection of the mRNA
sample, fluorescent nucleotides are incorporated into
cDNA during a reverse transcription reaction. Because
oligos can be synthesized with high fidelity and in high
quantities, and because DNA is a stable molecule, DNA
microarrays can be fabricated robustly and cheaply. A
large number of biologists were thus able to apply DNA
microarrays to their research and find new innovative uses
for them including gene expression profiling, SNP detec-
tion, tiling arrays, and ChIP-chip applications.
Protein arrays were predicted to impact our understand-
ing of protein structure and function, in the same way that
DNA arrays provided insight into gene expression and
regulation [4,5]. Unfortunately generating and applying
protein arrays had one significant impediment: proteins!
Thousands of purified proteins were required for a
protein array. The spotting process itself was also sub-
optimal as proteins are prone to unfolding, especially
when deposited and dried on a substrate. Protein arrays
not only required an exorbitant amount of work, but alsoughput protein biochemistry, Curr Opin Biotechnol (2010), doi:10.1016/j.copbio.2010.08.010
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arrays, two ssDNA probes need to anneal on the array to
be detected. These interactions generally have a Kd in the
picomolar range and a kinetic dissociation rate on the
order of 104 s1 to 105 s1 (t1/2 = 96 min to 2 hours)
even for relatively short 20 bp long oligos [6]. Protein
interactions on the other hand can range from micromolar
to picomolar affinities and kinetic dissociation rates can
reach up to 10 s1 (t1/2 = .07 s) [7,8]. Interactions with low-
affinity and high off-rates are lost during stringent wash
steps necessary to reduce non-specific background signal.
Even though protein arrays in principle are a powerful
tool, the difficulty of generating the arrays, and the fact
that protein interactions are significantly more difficult to
measure than DNA interactions, have thus far prohibited
protein arrays from reaching their full potential.
Recent technological developments have addressed the
issues associated with first generation protein arrays. The
invention of DNA to protein arrays (DTPAs) using in
vitro transcription/translation (ITT) circumvents many of
the difficulties associated with cloning, expressing, pur-
ifying, and spotting of proteins. DTPAs have been shown
to be able to produce hundreds to thousands of proteins in
parallel, making it possible for a single researcher to
generate large protein arrays. The second technological
advance is the integration of novel and existing methods
for measuring molecular interactions allowing proteins to
be characterized quantitatively and with better sensi-
tivity. The integration of DTPAs and novel detection
mechanisms into a single microfluidic device platform is a
significant step toward automating these methods, and
increasing throughput in protein biochemistry.
In vitro protein synthesis
In 2004 Ramachandran et al. developed a method for
transforming spotted DNA arrays into protein arrays,
termed nucleic acid programmable protein array (NAPPA)
[9,10]. Expression-ready biotinylated plasmid DNA is
co-spotted on a glass substrate together with a biotinylated
antibody. Both the plasmid DNA and antibody are
immobilized to the substrate surface by streptavidin. To
transform the DNA array into a protein array the entire
substrate is submerged in ITT reaction, which transcribes
and translates the plasmid DNA into protein. The syn-
thesized protein is then locally immobilized by the co-
spotted antibody. This approach has multiple advantages
over spotted protein arrays: firstly, plasmid DNA can be
generated using established molecular biology methods
amenable to high-throughput; secondly, spotted DNA/
antibody arrays aremore robust than spottedprotein arrays;
and thirdly, theproteins are synthesizedandpurified inone
step, eliminating the most labor intensive aspects of gen-
erating spotted protein arrays.
NAPPA effectively solved the problem of generating
protein arrays, but it also has a few shortcomings. ThePlease cite this article in press as: Maerkl SJ. Next generation microfluidic platforms for high-thro
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generation also requires long and tedious cloning and
transformation steps. Angenendt et al. have shown that
PCR products can serve directly as templates for protein
synthesis and protein array production, further streamlin-
ing the approach [11]. A second problem associated with
the NAPPA method is that synthesis is not compartmen-
talized. This gives rise to large spots and requires large
distances between spots to avoid cross-contamination in
turn limiting spot density. Tao and Zhu developed an
interesting variation based on spotted mRNA molecules
and puromycin based capture of the synthesized proteins
[12]. This method has been shown to produce very small
spots, and contamination is eliminated as only protein
synthesized locally from the spot is effectively captured
by the puromycin. Of course mRNA is not the most
optimal molecule to be used in the NAPPA approach,
but the approach by Tao and Zhu may give rise to
interesting alternative applications.
Integration ofDTPAs andmicrofluidics has recently been
demonstrated for the synthesis and characterization of S.
pneumoniae proteins [13] and synthetic transcription fac-
tor mutants [14]. In microfluidic DTPAs, DNA templates
are spotted on an epoxy coated slide. The DNA array is
aligned to a microfluidic device with up to 2400 unit cells
[14,15] so that each DNA spot is enclosed by a micro-
fluidic chamber. To generate the DTPA the device is
loaded with ITT reaction. The proteins are ultimately
captured by antibodies in an adjacent chamber, generat-
ing a protein array (Figure 1). There are several advan-
tages to combining DTPAs with microfluidics. First, all
synthesis reactions are compartmentalized and comple-
tely segregated from one another, eliminating cross-con-
tamination. Compartmentalization also gives rise to the
possibility for combinatorics and multiplexed expression
of proteins. For example, two proteins can be co-
expressed in a single chamber and consequently tested
for interaction [13]. Alternatively it is also possible to
express a protein in the presence of a small target mol-
ecule such as dsDNA oligos or drugs to assess the effect of
these small compounds [14,16]. Most importantly, integ-
ration of DTPAs with microfluidics also allows integration
with advanced detection mechanisms, and therefore sim-
ultaneously addresses both shortcomings of the classical
protein arrays, namely protein synthesis and detection.
The various methods for integrated detection are dis-
cussed in the next section.
Integrated interaction measurements
Sensitive and scalable methods for protein characteriz-
ation are equally important aspects for high-throughput
protein biochemistry, aside from large-scale protein syn-
thesis. These generally focus on measuring molecular
interactions and characterizing the parameters governing
these interactions. Detection methods can be roughly
divided into two categories. The first category of methodsughput protein biochemistry, Curr Opin Biotechnol (2010), doi:10.1016/j.copbio.2010.08.010
www.sciencedirect.com
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Figure 1
Schematic process of DNA to protein arrays on a microfluidic device. A photograph of 3 of the 2400 unit cells contained on the microfluidic device is
shown on the left. (a) Each unit cell is programmed with an expression ready template of DNA, and the detection area is derivatized with an antibody.
(b) The device is loaded with ITT reaction mixture, and each unit cell is compartmentalized. The device is incubated for one to two hours, allowing for
protein synthesis to take place. The synthesized protein is localized to the detection area by the previously immobilized antibody. (c) The detection
area can be washed, removing any unwanted ITT material, and is now ready for functional assays.requires the fluorescent labeling of at least one component
being measured. Fluorescent resonance energy transfer
(FRET) [17] and fluorescence correlation spectroscopy
(FCS) or fluorescent cross-correlation spectroscopy
(FCCS) [18] are the best known examples. A recently
developed method based on the mechanically induced
trapping of molecular interactions (MITOMI) [15] is
another method which requires fluorescent labeling of
one component and surface localization of the interaction.
The methods in the second category do not require label-
ing but do require that the interactions are localized to a
surface. Surface plasmon resonance (SPR) is the most well
established method of this kind [19,20]. Other promising
new technologies are based on nanowires, optical micro-
cavities, and nanomechanical resonators.
FRET
FRET occurs between two fluorophores, a donor and
acceptor pair, that are in close proximity (distance of
10 nm or below). If the donor is excited and the acceptor
is in close proximity, the energy can be transferred
radiationless to the acceptor, which then emits a photon
at a red shifted wavelength (Figure 2a). FRET can thus
be used as a molecular ruler, as the transfer between
donor and acceptor is strongly dependent on the distance
between the two. Ridgeway et al. have used amicrofluidic
device and FRET to measure the kinetics of binding of a
rRNA and ribosomal protein [21] (the authors also used
FCS, which is described in the next section). Because
FRET is very sensitive to distance it generally requires
precise knowledge of the molecule and is much more
readily applied to DNA or RNA containing complexesPlease cite this article in press as: Maerkl SJ. Next generation microfluidic platforms for high-thro
www.sciencedirect.comthan pure protein–protein interactions. FRET is unique
in its ability to provide information on the conformational
state of a protein or protein complex and thus makes it an
interesting method for the high-throughput interrogation
of protein dynamics as a function of sequence space.
Another FRET method that is suitable for measuring
protein interactions is the use of two fluorescent proteins,
each coupled to a different target protein (A and B).
Interaction of the proteins ‘A’ and ‘B’ brings the two
fluorescent proteins together leading to FRET (Figure
2a). The advantage of this method is that the fluorescent
proteins can be genetically encoded, and large libraries
of chimeric proteins can be generated. The drawback of
FRET based methods is the inherent sensitivity of
FRET to distance. It is thus possible that two interacting
proteins are geometrically oriented in such a way that the
two fluorescent proteins are not in close enough proximity
for efficient FRET.
FRET is thus somewhat suboptimal for large-scale
exploratory methods for detecting new protein inter-
actions. Nonetheless it remains an exceedingly sensitive
and informative method for characterizing known and
well defined interactions, and in the right system could
very well be scaled to high-throughput for interrogating
protein sequence–structure relationships.
FCS/FCCS
FCS and FCCS are methods based on measuring the
dwell time of a fluorescent molecule in a small illumi-
nated volume (Figure 2b). The dwell time of moleculesughput protein biochemistry, Curr Opin Biotechnol (2010), doi:10.1016/j.copbio.2010.08.010
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Figure 2
Summary of fluorscent-based (a)–(c) and label-free (d)–(e) methods for detecting molecular interactions.in the illumination spot and therefore the autocorrelation
function of the sample depend on the diffusion coeffi-
cient (D) of the molecule. FCS can therefore measure the
concentration of a sample, as well as determine the
diffusion coefficient of a molecule. Binding of another
molecule to the labeled molecule causes D to decrease
which is detected by FCS. In FCCS both molecules are
labeled, and can be said to be interacting if their fluor-
escence signals are temporally correlated with one
another. A few reports show that FCS or FCCS can be
coupled to microfluidic devices. Chou et al. quantitated
epidermal growth factor receptor (EGFR) and its inter-
action with Src and STAT3 [22]. Ridgeway et al. imple-
mented a two-photon detection mechanism to reduce the
amount of photobleaching of the sample and with single
molecule sensitivity [21].
Unlike with FRET based methods, steric constraints on
the distance between the fluorescent proteins is not
important in FCCS. The drawback is that FCS and FCCS
require fairly dilute samples, which in turn increase the
time required to acquire a statistically sufficient number of
counts leading to lengthy interrogation times.Even a 1 minPlease cite this article in press as: Maerkl SJ. Next generation microfluidic platforms for high-thro
Current Opinion in Biotechnology 2010, 22:1–7interrogation time per sample would require a total of 16
hours for 1000 samples, and interrogation times of 10 min
andmore are not uncommon. Spatial parallelization ofFCS
and FCCS measurements may be possible through dif-
fractive optical elements (DOEs) [23], or the use of
EMCCD cameras as detector arrays [24,25]. The latter
method may profit in particular from the integration with
microfluidics, as the z-dimension of the sample depth can
be precisely controlled in amicrofluidic environmentwith-
out the need for specialized optics. FCS and FCCS are
promising optical methods that could see increased appli-
cation to high-throughput protein biochemistry.
MITOMI
MITOMI is a novel opto-mechanical method for measur-
ing molecular interactions [15] (Figure 2c). The
method is based on capturing interacting molecules be-
tween two surfaces on a highly integrated microfluidic
device fabricated by multilayer soft lithography [26,27],
followed by optical quantitation of the trappedmolecules.
To measure the interaction of a two component system,
say between protein A and protein B, protein A is loca-
lized to the surface. Protein B is added to the solution andughput protein biochemistry, Curr Opin Biotechnol (2010), doi:10.1016/j.copbio.2010.08.010
www.sciencedirect.com
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the microfluidic channel in which the interaction takes
place is collapsed, bringing it in direct contact with the
surface to which protein A has been localized. Consequen-
tially, all unbound solvent and solute molecules, including
unbound protein B, are excluded from the detection area,
leaving only protein A and the bound fraction of protein B
behind. For detection purposes protein A and B can be
labeled with fluorescent antibodies, or if synthesized by
ITT, through residue specific incorporation of a fluores-
cently labeled lysine, or fluorescent proteins. MITOMI is
able to derive absolute binding affinities through multiple
dilution series. MITOMI also can capture interactions
between weakly associating molecules and transient com-
plexes.Thekinetics of association anddissociation can also
be measured by MITOMI, through the rapid and precise
temporal control of the time that the detection area is
available for interaction. Using this approach hundreds of
on-rates and off-rates can be measured in parallel on a
single device [28,29].
MITOMI is exceedingly easy to scale. No complex
optical setups are required to readout the devices. In
the first MITOMI experiments 2400 interactions were
measured in parallel on a single device, and multiple
experiments could be run in a short amount of time by a
single researcher. It was also shown that MITOMI is
applicable to a wide variety of interaction measurements
including protein–DNA [14,15], protein–RNA [16], and
protein–protein [13]. In one experiment it was shown
that 100 transcription factor variants could each be
measured against 64 target DNA sequences requiring
over 19 200 independent interaction measurements
[14]. In another example 43 S. pneumoniae proteins were
characterized in a total of 14 792 interaction experiments
[13]. The current throughput of MITOMI is orders of
magnitude above any other currently available method,
speaking for its ease of integration and simplicity.
SPR
SPR is probably the best known method for characteriz-
ing the kinetics of protein interactions [19] (Figure 2d).
SPR requires a gold surface which is derivatized with a
protein layer. Binding of molecules to the gold layer can
be detected as a change in incident angle or wavelength,
which is dependent on the refractive index of the inter-
face. Mass transfer to the surface can be detected in real-
time, allowing on-rates and off-rates to be measured. SPR
was integrated with microfluidics numerous times [30–
32]. The most recent example comes from Ouellet et al.,
who adopted a complex microfluidic device [26] to per-
form 264 independent SPR measurements [33].
Nanowires, optical microcavities, nanomechanical
resonators
A number of novel methods are showing potential for
characterizing molecular interactions and integration withPlease cite this article in press as: Maerkl SJ. Next generation microfluidic platforms for high-thro
www.sciencedirect.commicrofluidic devices. Many of the methods mentioned in
this section are still in early development, but will likely
reach adequate maturity to assess whether they can be
applied to large-scale protein interaction measurements.
Nanowires are a promising new method for detecting
protein interactions in high-throughput [34,35]
(Figure 2e). Binding of molecules to a nanowire changes
the conductivity of the wire which can be readily detected.
As the readout is purely electrical and does not require any
optics, nanowires promise to be a very effectivemethod for
integration with microfluidic devices.
Optical sensors based on ultrahigh quality factor whisper-
ing-gallery microcavities have recently been demon-
strated to be able to detect label-free single molecule
binding events [36]. This potential for ultra-high sensi-
tivity makes microcavities interesting candidates where
sensitivity is the most important parameter [37]. Integ-
ration with microfluidics is somewhat more complicated
and highly parallel measurements are not yet feasible.
Nanomechanical resonators have recently been applied to
measuring the binding of molecules to the surface of the
resonator. Nanomechanical resonators measure changes
in their weight through changes in their resonance fre-
quency. High sensitivity generally requires the resonators
to resonate at high-frequency, which excludes their use in
liquids (or air). Burg et al. have developed an ingenious
method that circumvents the damping problems associ-
ated with liquid, by routing the liquids inside of the
cantilever [38]. As with optical microcavities integration
and fabrication of these devices is more complicated, but
also may soon see sufficient improvement to make the
technique accessible.
Conclusion
Recent technological and methodological advances are
enabling protein biochemistry by drastically increasing
the throughput of protein synthesis and protein charac-
terization. DTPA methods make it possible to synthesize
thousands of proteins in parallel. MITOMI microfluidic
platforms integrate DTPAs and sensitive detection
methods to both synthesize and characterize protein in
high-throughput. MITOMI is currently the only high-
throughput, integrated platform that has been applied to
actual systems biology problems, such as measuring the
binding energy landscape of transcription factors, gener-
ating protein-interaction networks, and measuring the
functional consequence of mutations in transcription
factors. Other detection methods such as FRET, FCS,
and SPR, will also likely soon be scaled up and applied to
pertinent problems in the field, but current examples are
either low-throughput, or have only been applied to proof
of principle systems. Other promising methods based on
nanowires, optical microcavities, and nanomechanical
resonators will likely require more time to reach the sameughput protein biochemistry, Curr Opin Biotechnol (2010), doi:10.1016/j.copbio.2010.08.010
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for diagnostics and related problems can be expected
sooner. It is an exciting time for the development of
high-throughput methods for protein synthesis and
characterization. Genomic sequences have already
become a commodity, and gene synthesis costs are
expected to fall as drastically as sequencing costs, making
it soon possible to order hundreds to thousands of syn-
thetic genes (microfluidics may also prove to be the
enabling technology in that field). Together, these two
methods will make it possible to obtain expression ready
DNA templates for genes from any organism, including
unculturable and pathogenic ones. Gene synthesis will
also enable the generation of defined sequence variants of
a given protein. These methods in combination with
novel microfluidic platforms such as MITOMI, will make
it possible to express and characterize proteins from
synthetic DNA, providing a unique opportunity to answer
a wide variety of questions related to protein structure
and function that were previously inaccessible.
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